Daily BriefsEvent-Driven

Daily Brief Event-Driven: CATL (3750 HK): Reassessing Index Fast Entry; Need Overallotment Exercised by Tomorrow and more

In today’s briefing:

  • CATL (3750 HK): Reassessing Index Fast Entry; Need Overallotment Exercised by Tomorrow
  • Melco (200 HK) Trading “Cheap” Into Rights Issue
  • [Japan Buybacks] ShinEtsu Chem (4063) – How the FCSR Works
  • Surge in ETF Trading Share on KOSPI: Spot Dislocation Opportunities from Leverage Trades
  • Samsung Electronics’ Phase 2 Buyback Disposal Plan Virtually Finalized: Two Key Trading Implications
  • Mayne Disagrees With Cosette On MAC


CATL (3750 HK): Reassessing Index Fast Entry; Need Overallotment Exercised by Tomorrow

By Brian Freitas

  • CATL (3750 HK) is trading at a 6.9% premium to Contemporary Amperex Technology (CATL) (300750 CH) – if that is due to expectations of Fast Entry, that premium could drop.
  • CATL (3750 HK) has not announced the overallotment option as exercised and that puts Fast Entry at risk. An announcement prior to the close tomorrow could lead to Fast Entry.
  • The earliest inclusion could be at the close on 30 May while the other global index inclusion looks likely in December.

Melco (200 HK) Trading “Cheap” Into Rights Issue

By David Blennerhassett


[Japan Buybacks] ShinEtsu Chem (4063) – How the FCSR Works

By Travis Lundy

  • Late April, Shin Etsu Chemical (4063 JP) announced a huge ¥500bn 200mm shares (10.2%) buyback. That was never ever going to happen. That needed a ¥2500 share price, not ¥4300+.
  • But it was big, and started in late May. Today, they announced how. It is a “Japan ASR”, the Nomura version, this time with an interesting twist.
  • In response to a couple of reader questions today, I provide a brief overview of how these things work. 

Surge in ETF Trading Share on KOSPI: Spot Dislocation Opportunities from Leverage Trades

By Sanghyun Park

  • ETF trading topped 50% of KOSPI turnover in April—a first outside the March 2020 COVID crash—rising nearly 14 percentage points month-to-month despite a sharp overall volume drop.
  • Despite a 30% drop in KOSPI volume, leveraged and inverse ETFs surged 28% and 34%, led by ‘KODEX Leverage’ and ‘KODEX 200 Futures Inverse 2X’ hitting top ADV ranks.
  • Some local traders see opportunities in spot market dislocations amid volatility, futures rollovers, and ETF-driven supply-demand imbalances likely to persist from last month’s surge.

Samsung Electronics’ Phase 2 Buyback Disposal Plan Virtually Finalized: Two Key Trading Implications

By Sanghyun Park

  • If ₩500B comes from common shares, about 40M shares retire, raising Samsung Life and Fire stakes to 10.07%, requiring a ₩0.23T block sale to trim excess.
  • Slightly smaller than last time but still notable, the insurers acted fast in February. Expect a ~0.07% block trade soon, though price impact was mild previously.
  • Watch for preferred share outperformance as phase two buyback hits 0.66% common vs. 0.81% preferred (effective buyback assuming cancellation); similar dynamics may repeat in the larger ₩4T phase three buyback.

Mayne Disagrees With Cosette On MAC

By David Blennerhassett

  • As widely speculated, Cosette asserted to Mayne Pharma (MYX AU) on the 17th May a Material Adverse Change (MAC) has occurred.
  • Mayne disagrees, and views the pre-requisites for a MAC, as defined in the SID, have not been established. 
  • What now? The Scheme is not terminated. Both parties remain in consultation. If those talks are not satisfactory (say, a price reduction [my guess]), Cosette said it will walk. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars